ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VRAX Virax Biolabs Group Ltd

0.61
-0.039 (-6.01%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Virax Biolabs Group Ltd VRAX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.039 -6.01% 0.61 08:58:14
始値 安値 高値 終値 前日終値
0.66 0.61 0.6681 0.61 0.649
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2521:00PRNUSVirax Biolabs Launches Portfolio of Immune Profiling..
2024/4/1620:30PRNUSVirax Biolabs to Participate at ESCMID Global 2024
2024/3/1605:30PRNUSVirax Biolabs Announces Receipt of NASDAQ Notification..
2024/1/2307:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2307:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1221:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2121:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2121:30PRNUSVirax Biolabs Forges Strategic Research Collaboration with..
2023/12/2106:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/2106:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2106:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/1821:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1821:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
2023/12/1814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/1421:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1421:30PRNUSVirax Biolabs Group Limited Announces 1-for-10 Share..
2023/12/0820:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0606:06EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/11/0906:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0105:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1221:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0420:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1220:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1220:30PRNUSVirax Biolabs Group Announces Early-Access Program Launch of..
2023/9/0120:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0120:30PRNUSVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief..
2023/8/0321:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0320:30PRNUSNasdaq Approves 180-Day Extension for Virax Biolabs Group to..
2023/7/1820:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1820:30PRNUSVirax Biolabs Group Continues Growth and Expansion with the..
2023/6/1420:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
2023/5/0420:30PRNUSVirax Biolabs Group Announces Establishment of Regional..

最近閲覧した銘柄

Delayed Upgrade Clock